Table A4. Government Performance Results Act (GPRA) Sexually Transmitted Diseases Goals and Measures
GPRA Goals | Baseline | Annual Target | Actual Performance | Long-Term Goal | |||
2002 | 2004 | 2004 | 2010 | ||||
Goal 1: Reduction in PID (as measured by initial visits to physicians in women 15-44 years of age) | 197,000 | 163,000 | 132,000 | 168,000 | |||
a. Prevalence of Chlamydia in high-risk women ≤ 25 years | 10.1%* | 9.1%* | 9.7%* | 8.6%* | |||
b. Prevalence of Chlamydia in women ≤ 25 years in family planning clinics | 5.6%* | 5.2%* | 6.3%* | 4.9%* | |||
c. Incidence of Gonorrhea/100,000 population in women 15-44 years of age | 279 | 252 | 278 | 237 | |||
Goal 2: Elimination of Syphilis (as measured by incidence of P&S Syphilis/100,000 population) |
2.4 | 2.5 | 2.7 | 2.2 | |||
a. Incidence of P&S Syphilis/100,000 population - men | 3.8 | 4.5 | 4.7 | 4.2 | |||
b. Incidence of P&S Syphilis/100,000 population - women | 1.1 | 0.5 | 0.8 | 0.38 | |||
c. Incidence of Congenital Syphilis/100,000 live births | 10.2 | 5.4 | 8.8 | 3.9 | |||
d. Black:white rate ratio of P&S Syphilis | 8:1 | 3.5:1 | 5.6:1 | 3:1 |
GPRA Goals | Data Source |
1 | National Disease and Therapeutic Index (IMS Health). |
1a | National Job Training Program. |
1b | STD Surveillance System (STDSS), CDC, NCHSTP. |
1c | STD Surveillance System (STDSS), CDC, NCHSTP. |
2 | STD Surveillance System (STDSS), CDC, NCHSTP. |
2a | STD Surveillance System (STDSS), CDC, NCHSTP. |
2b | STD Surveillance System (STDSS), CDC, NCHSTP. |
2c | STD Surveillance System (STDSS), CDC, NCHSTP. |
2d | STD Surveillance System (STDSS), CDC, NCHSTP. |
*Median state-specific chlamydia prevalence among women was not adjusted for changes in laboratory test method and associated increases in test sensitivity.